EQAs for SARS-Cov-2 and other respiratory viruses open for registration
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
2021 EQA schemes open for registration
We are delivering 90 different EQA schemes covering 8 different core areas of genomics:
- Molecular genetics
- Molecular pathology (including FFPE and plasma based testing)
- Pharmacogenetics
- Technology (e.g NGS)
- Prenatal and Postnatal testing
- Virology
- Interlaboratory Comparisons (sample exchanges).
To browse our catalogue, or download a copy of the participant guide, please follow the link below.
We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
The latest news and press releases
Results from 2020 NGS pilot EQA schemes (germline and somatic) have been published today. Please login to your EMQN… https://t.co/rVyo2rabI2
Results from 2020 Pharmacogenetics pilot EQA scheme published today. Please log in to your EMQN to view them (https://t.co/jLPs3unl9E).
Are you doing Pharmacogenetic testing? Our EQA offers independent assessment of genotyping results & clinical inter… https://t.co/m8Aj5A2FpV
Results from 2020 MSI pilot EQA scheme published today. Please login to your EMQN account to view them (https://t.co/qbSN8m2RFf).
Results from 2020 PIK3CA pilot EQA scheme published today. Please login to your EMQN account to view them ( https://t.co/1XmYuX5n4Y).